about
Coronary heart disease policy models: a systematic reviewComparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studiesMissing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease.Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population.Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary preventionResearch capacity and training needs for non-communicable diseases in the public health arena in Turkey.Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008Decreasing trends in cardiovascular mortality in Turkey between 1988 and 2008.Estimating the potential contribution of stroke treatments and preventative policies to reduce the stroke and ischemic heart disease mortality in Turkey up to 2032: a modelling study.Use of evidence to support healthy public policy: a policy effectiveness-feasibility loopDecomposing socioeconomic inequalities in self assessed health in Turkey.Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000.Potential benefits of healthy food and lifestyle policies for reducing coronary heart disease mortality in Turkish adults by 2025: a modelling study.A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries.Determinants of inpatient costs of angina pectoris, myocardial infarction, and heart failure in a university hospital setting in Turkey.Health system challenges of cardiovascular disease and diabetes in four Eastern Mediterranean countries.Health policy analysis for prevention and control of cardiovascular diseases and diabetes mellitus in Turkey.Predicting the health impact of lowering salt consumption in Turkey using the DYNAMO health impact assessment tool.Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries.Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach.Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)--rationale and methods.Cardiovascular risk factor trends in the Eastern Mediterranean region: evidence from four countries is alarming.Determinants of Breast and Cervical Cancer Screening Uptake Among Women in Turkey.The association of job strain with coronary heart disease and metabolic syndrome in municipal workers in Turkey.High prevalence of cardiovascular risk factors in a Western urban Turkish population: a community-based study.Prevalence of low ankle brachial index and relationship with cardiovascular risk factors in a Western urban population in Turkey.Explaining inequalities in Health Care Utilization among Turkish adults: Findings from Health Survey 2008.Over 20,000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients.Waist:height ratio: a superior index in estimating cardiovascular risks in Turkish adults.Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.Life-years-gained from population risk factor changes and modern cardiology treatments in Ireland.Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality.Comparison of acellular pertussis-tetanus-diphtheria vaccines and whole-cell pertussis-tetanus-diphtheria vaccines in infancy.The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in IrelandMortality reductions in patients receiving exercise-based cardiac rehabilitation: how much can be attributed to cardiovascular risk factor improvements?Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000Misleading meta-analysis
P50
Q28200183-E581009A-020D-4E99-9539-AC9A2A884B4CQ28217496-098C03C1-79A9-49B9-9945-B10FAF05CF54Q28222464-33D0A6EE-FC8A-48A0-B986-AF1C67085D43Q28266074-D17173F8-DDFF-4C9C-B3DA-86E01B0CAFD0Q30806056-33BA66D0-CA16-4134-B40D-C38FC6764EF5Q31065396-6E28562A-AB40-4B46-BDD1-46EABEABBE07Q33998019-FB30C6EA-D9FF-4059-88A6-9616C91062EBQ34196341-8AA2B088-AE07-47F9-8FA7-FBA7B510DD21Q34522933-426FE816-3ADC-4963-A1DA-D58D0418900CQ35002144-D1AAF64A-CAA2-48E5-A1B7-A4766450B9F8Q35897075-30120A7D-1769-4819-AE14-28C3640D6FF2Q36423349-BEEBDBB5-6253-4D0A-B4A4-108F2B0D5DEAQ36521384-09D18D3D-F7BD-4E09-A306-B92C1BD179A1Q36933684-9430C6D6-6BE5-47EF-85FA-A528AFB4EBCDQ37101012-2B94D25E-BA90-4134-B8E1-300A88DB96C9Q37445000-597A098C-69F5-4B2E-A3C3-9A7AAD54DDB3Q37680408-4385CBD2-794F-4DA5-87DC-75646C3038CAQ38134156-79F2C235-1AF4-4D04-AF6B-6E2DAFE81B5FQ38210935-A2462390-2C46-46B2-BF45-8884722878E5Q38829364-C6A6B4A5-2D45-440C-BAF9-4C100849779DQ39021643-E284E87C-F4FC-42CA-96FE-44E2162E226EQ39084562-9248C13D-33AC-43F4-A5B8-DB958DD7A275Q39229251-4C97D1B3-8704-49C5-8761-8A7DE9F92DAAQ39503847-7A0555E8-C60F-46FA-B317-5C90548375B9Q39647210-97B9E428-4F37-43BC-86A3-E27FCFAA3DCAQ39772305-0B716880-4640-4B49-8FC9-A3649892DE75Q40069216-6DE8AA72-846E-4D4F-8D94-C8E5D5DC5318Q40079125-5BF58AAD-42CA-41BE-B373-C40316DE4E7EQ40326438-923B91E3-2F91-4351-8094-50DC4E7662FBQ42832216-733D9012-F2A2-469C-9921-CDB2DF4D9546Q43922977-00FE8012-9527-4571-975F-ACB432943A56Q44520744-42647FB9-ED50-4E51-8DCC-4803C5EDE5F9Q44781959-2D88532F-FAB7-447C-8289-A92A026E02C0Q45047412-3FB01A54-5A1E-4249-9EE9-9773BA5B5475Q45098886-E335247A-79AE-4169-BFF1-848A53EE5988Q54288814-5373BB20-2893-4571-843C-42E121D0998CQ61192538-4C18B858-FB5C-4F61-B5E1-A67A35FDAF54Q61192545-2B784262-10F1-41EE-9A46-CC59D30AAA20Q61192550-AA766593-0F65-42C1-AC60-EDCB2BE67820Q61192558-5C105164-6124-43AE-9C33-F39F24ABFE52
P50
description
araştırmacı
@tr
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Belgin Unal
@ast
Belgin Unal
@es
Belgin Unal
@nl
Belgin Ünal
@en
Belgin Ünal
@fr
Belgin Ünal
@tr
type
label
Belgin Unal
@ast
Belgin Unal
@es
Belgin Unal
@nl
Belgin Ünal
@en
Belgin Ünal
@fr
Belgin Ünal
@tr
altLabel
Belgin Unal
@en
prefLabel
Belgin Unal
@ast
Belgin Unal
@es
Belgin Unal
@nl
Belgin Ünal
@en
Belgin Ünal
@fr
Belgin Ünal
@tr
P106
P1559
Belgin Ünal
@tr
P21
P31
P496
0000-0002-4354-8266